Belluscura plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BELL.L research report →
Companywww.belluscura.com
Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
- CEO
- Robert Rauker
- IPO
- 2021
- Employees
- 35
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $3.01M
- P/E
- -0.07
- P/S
- 4.89
- P/B
- 0.07
- EV/EBITDA
- -0.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -509.22%
- Op Margin
- -2143.39%
- Net Margin
- -2243.45%
- ROE
- -97.35%
- ROIC
- -98.74%
Growth & Income
- Revenue
- $825.41K · -40.96%
- Net Income
- $-18,517,619 · -111.32%
- EPS
- $-0.14 · -110.53%
- Op Income
- $-17,691,721
- FCF YoY
- 31.62%
Performance & Tape
- 52W High
- $18.00
- 52W Low
- $0.49
- 50D MA
- $0.81
- 200D MA
- $5.59
- Beta
- 0.70
- Avg Volume
- 4.36M
Get TickerSpark's AI analysis on BELL.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BELL.L Coverage
We haven't published any research on BELL.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BELL.L Report →